Table 1 Clinical characteristics of the analyzed ICU patient cohort
From: Biometric covariates and outcome in COVID-19 patients: are we looking close enough?
Total | |
|---|---|
Total number of patients, n (%) | 81 (100) |
Age (mean ± SD), years | 64.3 ± 11.3 |
Male gender, n (%) | 54 (66.6) |
Length of stay ICU, days (mean ± SD) | 25.8 ± 22.0 |
MV, n (%) | 67 (83) |
Length of MV, days (mean ± SD) | 26.5 ± 20.6 |
ARDS, n (%) | 57 (70.4) |
Mild, n (%) | 1 (1.2) |
Moderate, n (%) | 21 (25.9) |
Severe, n (%) | 35 (43.2) |
Pulmonary Embolism, n (%) | 17 (21.0) |
Renal replacement therapy, n (%) | 46 (56.8) |
ECMO, n (%) | 16 (19.8) |
Mortality, n (%) | 29 (35.8) |